Literature DB >> 24444179

Adenovirus: the first effective in vivo gene delivery vector.

Ronald G Crystal1.   

Abstract

Mesh：

Year:  2014        PMID： 24444179      PMCID： PMC3900005          DOI： 10.1089/hum.2013.2527

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  97 in total

Review 1.  Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond.

Authors:  Johanna K Kaufmann; Dirk M Nettelbeck
Journal:  Trends Mol Med       Date:  2012-05-25       Impact factor: 11.951

Review 2.  Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications.

Authors:  Zachary C Hartman; Daniel M Appledorn; Andrea Amalfitano
Journal:  Virus Res       Date:  2007-11-26       Impact factor: 3.303

Review 3.  Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection.

Authors:  Rong-Fu Chen; Chun-Yi Lee
Journal:  Int Rev Immunol       Date:  2013-10-15       Impact factor: 5.311

Review 4.  Viruses in therapy--royal road or dead end?

Authors:  Matthias Dobbelstein
Journal:  Virus Res       Date:  2003-04       Impact factor: 3.303

5.  Disrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunity.

Authors:  Bishnu P De; Odelya E Pagovich; Martin J Hicks; Jonathan B Rosenberg; Amira Y Moreno; Kim D Janda; George F Koob; Stefan Worgall; Stephen M Kaminsky; Dolan Sondhi; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2012-12-21       Impact factor: 5.695

6.  Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.

Authors:  T K Rosengart; L Y Lee; S R Patel; T A Sanborn; M Parikh; G W Bergman; R Hachamovitch; M Szulc; P D Kligfield; P M Okin; R T Hahn; R B Devereux; M R Post; N R Hackett; T Foster; T M Grasso; M L Lesser; O W Isom; R G Crystal
Journal:  Circulation       Date:  1999-08-03       Impact factor: 29.690

Review 7.  Cancer therapy with local oncolysis and topical cytokine secretion.

Authors:  Masatoshi Tagawa; Kiyoko Kawamura; Taro Ueyama; Makoto Nakamura; Yuji Tada; Guangyu Ma; Quanhai Li; Nobuo Suzuki; Hideaki Shimada; Tekenori Ochiai
Journal:  Front Biosci       Date:  2008-01-01

Review 8.  New insights on adenovirus as vaccine vectors.

Authors:  Marcio O Lasaro; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2009-06-09       Impact factor: 11.454

9.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

Review 10.  Advances and future challenges in adenoviral vector pharmacology and targeting.

Authors:  Reeti Khare; Christopher Y Chen; Eric A Weaver; Michael A Barry
Journal:  Curr Gene Ther       Date:  2011-08       Impact factor: 4.391
View more
  97 in total

1.  Efficient Gene Transduction of Dispersed Islet Cells in Culture Using Fiber-Modified Adenoviral Vectors.

Authors:  Hiroyuki Hanayama; Kazuo Ohashi; Rie Utoh; Hirofumi Shimizu; Kazuya Ise; Fuminori Sakurai; Hiroyuki Mizuguchi; Hiroyuki Tsuchiya; Teruo Okano; Mitsukazu Gotoh
Journal:  Cell Med       Date:  2015-08-26

Review 2.  The transgenic animal platform for biopharmaceutical production.

Authors:  L R Bertolini; H Meade; C R Lazzarotto; L T Martins; K C Tavares; M Bertolini; J D Murray
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

3.  Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5.

Authors:  Eric Ehrke-Schulz; Wenli Zhang; Maren Schiwon; Thorsten Bergmann; Manish Solanki; Jing Liu; Philip Boehme; Theo Leitner; Anja Ehrhardt
Journal:  J Vis Exp       Date:  2016-01-28       Impact factor: 1.355

Review 4.  Getting genetic access to natural adenovirus genomes to explore vector diversity.

Authors:  Wenli Zhang; Anja Ehrhardt
Journal:  Virus Genes       Date:  2017-07-15       Impact factor: 2.332

Review 5.  Virotherapy: cancer gene therapy at last?

Authors:  Alan E Bilsland; Pavlina Spiliopoulou; T R Jeffry Evans
Journal:  F1000Res       Date:  2016-08-30

6.  Persistence of hAQP1 expression in human salivary gland cells following AdhAQP1 transduction is associated with a lack of methylation of hCMV promoter.

Authors:  C Zheng; B J Baum; X Liu; C M Goldsmith; P Perez; S-I Jang; A P Cotrim; L McCullagh; I S Ambudkar; I Alevizos
Journal:  Gene Ther       Date:  2015-07-16       Impact factor: 5.250

7.  In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration.

Authors:  Megumi Mathison; Vivek P Singh; Maria J Chiuchiolo; Deepthi Sanagasetti; Yun Mao; Vivekkumar B Patel; Jianchang Yang; Stephen M Kaminsky; Ronald G Crystal; Todd K Rosengart
Journal:  J Thorac Cardiovasc Surg       Date:  2016-09-23       Impact factor: 5.209

8.  Collusion between neutralizing antibodies and other immune factions in the destruction of adenoviral vectors.

Authors:  P J Klasse
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-19       Impact factor: 11.205

9.  Rapid and reliable healing of critical size bone defects with genetically modified sheep muscle.

Authors:  F Liu; E Ferreira; R M Porter; V Glatt; M Schinhan; Z Shen; M A Randolph; C A Kirker-Head; C Wehling; M S Vrahas; C H Evans; J W Wells
Journal:  Eur Cell Mater       Date:  2015-09-21       Impact factor: 3.942

Review 10.  Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Authors:  Maria J Chiuchiolo; Ronald G Crystal
Journal:  Ann Am Thorac Soc       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.